These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6785295

  • 1. Prolactin-secreting pituitary adenomas. V. Increased gonadotroph responsivity in hyperprolactinemic women with pituitary adenomas.
    Monroe SE, Levine L, Chang RJ, Keye WR, Yamamoto M, Jaffe RB.
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1171-8. PubMed ID: 6785295
    [No Abstract] [Full Text] [Related]

  • 2. The effect of long-term naloxone infusion on the response of gonadotropins to luteinizing hormone-releasing hormone and on plasma estradiol concentration in a patient with a prolactin-secreting pituitary adenoma.
    Lamberts SW, Timmers JM, de Jong FH.
    Fertil Steril; 1981 Nov; 36(5):678-81. PubMed ID: 6796442
    [No Abstract] [Full Text] [Related]

  • 3. Correlation of serum prolactin and LH response to stimulation with LH-RH before and after extirpation of pituitary adenomas with clinical outcome.
    Guitelman A, Aparicio NJ, Mancini A, Encinas MT, Levalle O, Schally AV.
    J Clin Endocrinol Metab; 1977 Oct; 45(4):810-3. PubMed ID: 334790
    [No Abstract] [Full Text] [Related]

  • 4. [Prolactin adenoma. Study of gonadotrophic function by the sassoles G LHRH test].
    Tourniaire J, Pallo D, Fèvre M, Ponsin G, Mazenod B, Bachelot I, Sassolas G.
    Nouv Presse Med; 1975 Apr 26; 4(17):1263-6. PubMed ID: 1098013
    [Abstract] [Full Text] [Related]

  • 5. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME, Judd SJ, Gilliland GB, Yen SS.
    J Clin Endocrinol Metab; 1979 Apr 26; 48(4):718-20. PubMed ID: 429515
    [Abstract] [Full Text] [Related]

  • 6. [Hypophyseal gonadotropins after GnRH in patients with pituitary tumors].
    Morosini PP, Carletti P, Campanella N, Ferretti GF.
    Boll Soc Ital Biol Sper; 1980 Jun 30; 56(12):1243-7. PubMed ID: 6779829
    [Abstract] [Full Text] [Related]

  • 7. Pituitary-ovarian axis responsivity to prolonged gonadotropin-releasing hormone infusion in normal and hyperprolactinemic women.
    Caro JF, Woolf PD.
    J Clin Endocrinol Metab; 1980 Jun 30; 50(6):999-1004. PubMed ID: 6768765
    [No Abstract] [Full Text] [Related]

  • 8. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
    Rudolf K, Smid I, Kunkel S, Bazsa-Kassai Z.
    Zentralbl Gynakol; 1985 Jun 30; 107(14):894-8. PubMed ID: 3929499
    [Abstract] [Full Text] [Related]

  • 9. Gonadal function in fifty men with untreated pituitary adenomas.
    Snyder PJ, Bigdeli H, Gardner DF, Mihailovic V, Rudenstein RS, Sterling FH, Utiger RD.
    J Clin Endocrinol Metab; 1979 Feb 30; 48(2):309-14. PubMed ID: 218986
    [No Abstract] [Full Text] [Related]

  • 10. Pituitary microadenoma and hyperprolactinemia: a cause of unexplained secondary amenorrhea.
    Boyar RM, Kapen S, Weitzman ED, Hellman L.
    N Engl J Med; 1976 Jan 29; 294(5):263-5. PubMed ID: 811989
    [No Abstract] [Full Text] [Related]

  • 11. Responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas.
    Chanson P, Lahlou N, Warnet A, Roger M, Sassolas G, Lubetzi J, Schaison G, Bouchard P.
    J Endocrinol Invest; 1994 Feb 29; 17(2):91-8. PubMed ID: 8006338
    [Abstract] [Full Text] [Related]

  • 12. An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology.
    Cunningham GR, Huckins C.
    J Clin Endocrinol Metab; 1977 Feb 29; 44(2):248-53. PubMed ID: 402377
    [Abstract] [Full Text] [Related]

  • 13. Effects of naloxone on prolactin-secreting pituitary adenomas.
    Shima K, Chigasaki H, Seki K.
    Neurol Med Chir (Tokyo); 1990 Feb 29; 30(2):109-12. PubMed ID: 1695330
    [Abstract] [Full Text] [Related]

  • 14. Surgical treatment of prolactin-secreting microadenomas.
    Wiebe RH, Kramer RS, Hammond CB.
    Am J Obstet Gynecol; 1979 May 01; 134(1):49-55. PubMed ID: 375736
    [No Abstract] [Full Text] [Related]

  • 15. [Endocrinological analysis of pituitary adenomas associated with hyperprolactinemia (author's transl)].
    Sato O, Hotta H, Nakagawa T, Sohma F, Hasunuma M, Tsuchita H, Tanabe S, Kobayashi K, Inoue Y.
    No To Shinkei; 1981 Nov 01; 33(11):1115-23. PubMed ID: 6277351
    [No Abstract] [Full Text] [Related]

  • 16. New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist.
    McGrath GA, Goncalves RJ, Udupa JK, Grossman RI, Pavlou SN, Molitch ME, Rivier J, Vale WW, Snyder PJ.
    J Clin Endocrinol Metab; 1993 May 01; 76(5):1363-8. PubMed ID: 8496331
    [Abstract] [Full Text] [Related]

  • 17. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC, Bang F, Laurberg P.
    Growth Regul; 1994 Jun 01; 4(2):63-7. PubMed ID: 7950904
    [Abstract] [Full Text] [Related]

  • 18. [Endocrine diagnosis of pituitary adenomas (author's transl)].
    Nakai Y, Oki S, Nakao K, Fukada J, Kinoshita F, Tanaka K, Tsukada T, Imura H.
    No To Shinkei; 1981 May 01; 33(5):431-40. PubMed ID: 6266437
    [No Abstract] [Full Text] [Related]

  • 19. Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.
    Sassolas G, Lejeune H, Trouillas J, Forest MG, Claustrat B, Lahlou N, Loras B.
    J Clin Endocrinol Metab; 1988 Jul 01; 67(1):180-5. PubMed ID: 2967850
    [Abstract] [Full Text] [Related]

  • 20. [Hypophyseal gonadotropins after GnRH in patients with hypophyseal tumors and after hypophysectomy].
    Morosini PP, Campanella N, Ferretti GF, Carletti P.
    Boll Soc Ital Biol Sper; 1980 Jun 30; 56(12):1248-51. PubMed ID: 6779830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.